Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 4 | GH9702 | — |
she got Omicron 3 weeks after receiving that dose; she got Omicron 3 weeks after receiving that dose; This is a spontaneous report received from a Consumer or other non HCP. An 84-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Dec2021 as dose 4, (booster) single (Lot number: GH9702) at the age of 80 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 06Mar2021 as dose 1, single (Lot number: EN6199), on 27Mar2021 as dose 2, single (Lot number: EP7534) and on 28Oct2021 as dose 3, (booster) single (Lot number: FF2593) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "she got Omicron 3 weeks after receiving that dose".